Last reviewed · How we verify
Chemotherapy-Induced Hyperuricemia
Approved treatments
- Aloprim · Casper Pharma Llc
Aloprim works by inhibiting the enzyme xanthine oxidase, which is responsible for producing uric acid in the body.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Chemotherapy-Induced Hyperuricemia patent landscape — cliff calendar, originator estates, attackable patents
- Chemotherapy-Induced Hyperuricemia treatment landscape brief
- Chemotherapy-Induced Hyperuricemia treatment updates RSS
Frequently asked questions about Chemotherapy-Induced Hyperuricemia
What drugs treat Chemotherapy-Induced Hyperuricemia?
Tracked treatments include Aloprim.
What is the treatment for Chemotherapy-Induced Hyperuricemia?
Standard treatment for Chemotherapy-Induced Hyperuricemia includes Aloprim. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Chemotherapy-Induced Hyperuricemia patent cliff · Chemotherapy-Induced Hyperuricemia CI report
- Treatment: Aloprim · Casper Pharma Llc
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing